Allscripts (MDRX) Misses Q1 EPS by 1c, Affirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Allscripts announces first quarter 2018 results
May 3, 2018 4:02 PM EDTReported first quarter growth of 24% in GAAP revenue to $514 million, 25% in non-GAAP revenue to $519 million; First quarter GAAP EPS of ($0.22) reflecting acquisition transaction fees, growth of 23% in non-GAAP EPS to $0.16Delivered record first quarter bookings of $304 millionAnnounced agreement to acquire HealthGrid to expand FollowMyHealth® patient engagement platform
CHICAGO, May 03, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2018.
First... More
